David P. Benziger - Concepedia

Author

David P. Benziger

Also Known As

D Benziger, D P Benziger, D. Benziger, D. P. Benziger, D.P. Benziger, DAVID BENZIGER, DAVID P. BENZIGER, David Benziger, David P. Benziger

Publications

1.7K

Citations

H-Index

Concepts

All Affiliations

Cubist Pharmaceuticals (United States)Sterling Research Group (United States)University of Cincinnati Purdue Pharma (United States)Purdue Pharma (Canada)

About

David P. Benziger is an author at Cubist Pharmaceuticals (United States) specializing in pharmacology, medicine, and pharmacokinetics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	17	784
2	Health Sciences	4	4	398
3	Biochemistry	4	4	104
4	Endocrinology	3	3	74
5	Diabetes	1	1	15

David P. Benziger

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
Pharmacokinetics and Tolerability of Daptomycin at Doses up to 12 Milligrams per Kilogram of Body Weight Once Daily in Healthy Volunteers Mark Benvenuto, David P. Benziger, Sara Yankelev, Antimicrobial Agents and Chemotherapy Antimicrobial SusceptibilityHealth SciencesMedicineHealthy VolunteersAntibiotic Adjuvant	2006	320
Pharmacokinetic-pharmacodynamic relationships of controlled-release oxycodone* Robert F. Kaiko, David P. Benziger, Ronald D. Fitzmartin, Clinical Pharmacology & Therapeutics	1996	182
Prolonged Intercostal Nerve Blockade in Sheep Using Controlled-release of Bupivacaine and Dexamethasone from Polymer Microspheres Christiane Drager, David P. Benziger, Feng Gao, Anesthesiology	1998	156
Pharmacokinetics and Safety of Intravenous Ceftolozane-Tazobactam in Healthy Adult Subjects following Single and Multiple Ascending Doses Benjamin Miller, Ellie Hershberger, David P. Benziger, Antimicrobial Agents and Chemotherapy Mean ValuesHealthy Adult SubjectsPharmacotherapyPharmacodynamic ModelingPre-clinical Pharmacology	2012	117
The Pharmacokinetic and Pharmacodynamic Characteristics of a Long-Acting Growth Hormone (GH) Preparation (Nutropin Depot) in GH-Deficient Adults David M. Cook, Beverly M. K. Biller, M. L. Vance, The Journal of Clinical Endocrinology & Metabolism	2002	93
A pilot study of high-dose short duration daptomycin for the treatment of patients with complicated skin and skin structure infections caused by gram-positive bacteria David Katz, Kimberly C. Lindfield, Judith N. Steenbergen, International Journal of Clinical Practice	2008	89
Single-Dose Pharmacokinetics of Daptomycin in Children With Suspected or Proved Gram-Positive Infections Susan M. Abdel‐Rahman, David P. Benziger, Richard F. Jacobs, The Pediatric Infectious Disease Journal	2008	74
Differential Effects of Food on the Bioavailability of Controlled-Release Oxycodone Tablets and Immediate-Release Oxycodone Solution David P. Benziger, Robert F. Kaiko, Jahanara B. Miotto, Journal of Pharmaceutical Sciences	1996	52
Single-dose Pharmacokinetics and Tolerability of Daptomycin 8 to 10 mg/kg in Children Aged 2 to 6 Years With Suspected or Proved Gram-positive Infections Susan M. Abdel‐Rahman, Gurudatt Chandorkar, Ronda L. Akins, The Pediatric Infectious Disease Journal Antibiotic AdjuvantDaptomycin 8PharmacotherapyAntimicrobial ChemotherapyPharmacokinetic Analysis	2011	52
In vitro stimulation of hepatic glycogen phosphorylase activity by epinephrine and glucagon in the brown bullhead, Ictalurus nebulosus Bruce L. Umminger, David P. Benziger General and Comparative Endocrinology Animal PhysiologyGlycosylationBiochemistryBrown BullheadAnimal Science	1975	50

Page 1